AR and prostate carcinoma: UA-inhibited cell proliferation in both androgen receptor-positive and androgen receptor-negative cells in prostate cancer [63] due to the synergistic action of p38-MAPK activation and suppression of Wnt/β-catenin signaling in HepG2 cells [64] and decreased snail protein expression and activity in lung cancer cells [65].